2B77 Stock Overview
An exchange traded fund launched by BlackRock Asset Management Ireland Limited.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares IV Public Limited Company - iShares Ageing Population UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$7.01 |
52 Week High | US$7.10 |
52 Week Low | US$5.53 |
Beta | 0 |
11 Month Change | 2.86% |
3 Month Change | 4.04% |
1 Year Change | 17.46% |
33 Year Change | 6.89% |
5 Year Change | n/a |
Change since IPO | 50.17% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
2B77 | DE Capital Markets | DE Market | |
---|---|---|---|
7D | 0.2% | 1.4% | 1.1% |
1Y | 17.5% | 30.5% | 10.7% |
Return vs Industry: 2B77 underperformed the German Capital Markets industry which returned 29.6% over the past year.
Return vs Market: 2B77 exceeded the German Market which returned 7.6% over the past year.
Price Volatility
2B77 volatility | |
---|---|
2B77 Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2B77 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2B77's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | n/a | www.ishares.com/uk/institutional/en/products/284218/AGED |
iShares IV Public Limited Company - iShares Ageing Population UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe.
iShares IV Public Limited Company - iShares Ageing Population UCITS ETF Fundamentals Summary
2B77 fundamental statistics | |
---|---|
Market cap | €392.23m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 2B77 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2B77 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 2B77 perform over the long term?
See historical performance and comparison